Plain-English translation of NCT05593640 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are investigating how thromboxane A2, a natural substance your body produces, may play a role in osteoarthritis of the knee. This study will look at blood samples and fluid from your knee joint to understand whether levels of this substance are connected to how osteoarthritis develops. The goal is to find new ways to treat osteoarthritis through diet or medication.
Doctors don't fully understand all the reasons why osteoarthritis develops, and current treatments don't work for everyone. By studying this natural substance, researchers hope to discover new approaches that could prevent or slow down cartilage damage and improve treatment options for people with knee osteoarthritis.
You likely qualify if…
You likely don't qualify if…
As a participant, you would have blood drawn and fluid collected from your knee joint so researchers can measure levels of the substance being studied. The study involves a small group of 20 people total and appears to focus on collecting these samples to compare with information about your osteoarthritis. Your doctor can explain the specific schedule and details of your visits.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
France
French Society of Rheumatology
Enrollment target
~20 participants
Started
September 2022
Primary completion
September 2023
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Christian ROUX, MD, PhD
Centre Hospitalier Universitaire de Nice
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.